Cervical cancer is cancer of the cervix, the lower part of the uterus that connects to the vagina.
Human Papilloma Virus Types 16 and 18 cause cervical cancer.
Cervical cancer is the second largest killer of women among cancers worldwide.
Human Papilloma Virus is a sexual transmitted disease that can spread through sexual intercourse with an infected person.
The other sexual transmitted diseases are syphilis, chlamydia, gonorrhea and many more.
When you become infected with HPV virus, the healthy cells in your cervix begin to change into abnormal cells, which can develop in the lining of the cervix.
If not discovered early and left untreated, these abnormal cells can become pre-cancerous cells and then turn into cervical cancer.
Although you can detect cervical cancer early with Pap smear (a procedure where scraped cells from the cervix are examined under a microscope) — it still kills nearly 300,000 women per year. Women with certain types of the human papilloma virus (HPV) are vulnerable to developing cervical cancer.
Merck developed a new cervical cancer vaccine, which is recently approved by FDA (Food And Drug Association) to protect you against the virus responsible for cervical cancer – Garadsil.
The cervical cancer vaccine could prevent up to 70 percent of cases of cervical cancer. This is the first vaccine designed to protect from this cancer.
In the United States, about 10,000 new cases of cervical cancer are diagnosed yearly. Approximately 4,000 women die of cervical cancer each year.
Gardasil has been proved effective in preventing cervical cancer. It is a cervical cancer vaccine that fights against the virus that causes cancer of the cervix. This vaccine will be injected three times over an eight-month period to prevent cervical cancer.
Gardasil, a cervical cancer vaccine, blocks two cervical cancer-causing viruses – HPV types 16 and 18 — to prevent the cancer at initial stages. The vaccine stops cervical cancer before even the first step can begin.
According to a study carried out by Gardasil makers, Merck, less than 20% of American women know that HPV is the main cause of cervical cancer.
GlaxoSmithKline developed another cervical cancer vaccine, Cervarix, to protect against HPV, which is a known cause for cervical cancer. Cervarix does not protect from genital warts, which Gardasil does. Gardasil protects up to 90% of cases of genital warts.
Studies have shown that women between the ages of 15 and 25 who receive Cervarix have protected 100% against the two strains of HPV for about four to five years.
How widely the vaccine will be used in the USA will be better known when the CDC makes its recommendations. The recommendations will be on various aspects of the vaccine, of which age will be the major aspect that is at what age a women should be given the vaccine.
This will then decide whether or not Pediatricians include cervical cancer vaccine in their childhood and adolescent.
The cervical cancer vaccines are not recommended for people that already infected with HPV as there is a higher risk of having precursors to cervical cancer.